Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Dr. Reddy's Laboratories Ltd.
NSE: DRREDDY
|
BSE: 500124
|
ISIN: INE089A01031
|
Industry: Pharmaceuticals
Estimates Beat
|
Mid-range Performer
1218.1000
11.00
(
0.91
%)
NSE
May 14, 2025
15:03 PM
Volume:
1.0M
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Dr. Reddy's Laboratories Ltd.
26 Jan 2023
Estimates Beat
1218.10
0.91%
Dr Reddy's Labs (HOLD): Strong US sales; recovery in EM and PSAI businesses
Hold:
Dr. Reddy's Laboratories Ltd.
by
BOB Capital Markets Ltd.
Target: 4700
Target
BOB Capital Markets Ltd.
Q3 revenue growth strong at 27% YoY to Rs 67.7bn, supported by US contribution and launches
Number of FII/FPI investors decreased from 927 to 911 in Mar 2025 qtr
More from Dr. Reddy's Laboratories Ltd.
Recommended
Market trades higher, Garden Reach's Q4 revenue beats Forecaster estimates by 33.3%,
Trendlyne Marketwatch |
14 May 2025, 02:42PM
Chart of the week: From partnerships to diversification: Dixon Technologies powers ahead to new highs
The Baseline |
14 May 2025, 09:48AM
Dr Reddy’s Labs struggles in its biggest market
|
18 Aug 2021